GDOCvsFTXHETF Comparison
VS
Goldman Sachs Future Health Care Equity ETF (GDOC) belongs to the Healthcare Technology segment. First Trust Nasdaq Pharmaceuticals ETF (FTXH) is part of the US Health Care segment. Both ETFs have the same top 1 sector exposures: Healthcare. GDOC is more expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.6% for FTXH. GDOC is up 4.02% year-to-date (YTD) with -$2M in YTD flows. FTXH performs better with 26.05% YTD performance, and +$1.11B in YTD flows. Run a side-by-side ETF comparison of GDOC and FTXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
GDOC vs FTXH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/18/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | GDOC FTXH | -1.38%+2.91% | +11.53%+16.24% | +4.02%+26.05% | +13.97%+49.52% | +19.50%+63.96% | n/a+72.99% |
| Flows | GDOC FTXH | -+$161M | -$3M+$1.10B | -$2M+$1.11B | -$3M+$1.11B | -$86M+$1.10B | -+$1.10B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | GDOC FTXH | +15.50%+19.83% | +15.27%+17.58% | +14.97%+17.00% | n/a+16.35% |
| Max drawdown | GDOC FTXH | -6.08%-5.41% | -15.39%-7.50% | -22.18%-19.32% | n/a-19.32% |
| Max drawdown duration | GDOC FTXH | 30d23d | 221d99d | 449d393d | n/a393d |
Trading data
GDOC | FTXH | |
Last sale 9/18/2026 at 1:30 PM | $37.02 | $41.09 |
| Previous close 09/17/2026 | $37.25 | $41.40 |
| Consolidated volume 09/17/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
GDOC
is actively managed and doesn’t replicate an indexGDOC | FTXH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/18/2026 at 1:30 PM
Live
Closed
GDOC | FTXH | |
|---|---|---|
| Last price | $37.02 | $41.09 |
| 1D performance | -0.62% | -0.74% |
| AuM | $19.46 M | $1.19 B |
| E/R | 0.75% | 0.6% |
Characteristics
GDOC | FTXH | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Goldman Sachs | First Trust |
| Benchmark | - | NASDAQ US Smart Pharmaceuticals Index |
| N° of holdings | 38 | 49 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | November 11, 2021 | September 20, 2016 |
| ESG | No | No |
Advertisement
Exposure
Countries
GDOC
USA
79.52%
Other
20.48%
FTXH
USA
95.79%
Other
4.21%
Sectors
GDOC
Healthcare
97.92%
Other
2.08%
FTXH
Healthcare
99.86%
Other
0.14%
Advertisement
Diversification
GDOC
Total weight of top 15 holdings out of 15
71.18%
FTXH
Total weight of top 15 holdings out of 15
66.98%
Top 15 holdings
Data as of July 31, 2026
GDOC
Eli Lilly & Co.
13.11%
Johnson & Johnson
8.63%
Merck & Co., Inc.
6.83%
UnitedHealth Group, Inc.
6.44%
Guardant Health, Inc.
4.41%
argenx SE
3.71%
AstraZeneca PLC
3.59%
Edwards Lifesciences Corp.
3.30%
Thermo Fisher Scientific, Inc.
3.30%
Agilent Technologies, Inc.
3.28%
DexCom, Inc.
3.23%
Apogee Therapeutics, Inc.
3.00%
Intuitive Surgical, Inc.
2.88%
Lonza Group AG
2.79%
Cencora, Inc.
2.67%
FTXH
Merck & Co., Inc.
7.58%
Eli Lilly & Co.
7.43%
AbbVie, Inc.
7.11%
Johnson & Johnson
6.78%
Bristol Myers Squibb Co.
6.61%
Amgen, Inc.
3.53%
Biogen, Inc.
3.52%
Vertex Pharmaceuticals, Inc.
3.43%
Viatris, Inc.
3.40%
Regeneron Pharmaceuticals, Inc.
3.34%
Pfizer Inc.
3.17%
Cardinal Health, Inc.
3.14%
Gilead Sciences, Inc.
3.03%
Incyte Corp.
2.48%
United Therapeutics Corp.
2.43%
Frequently asked questions about GDOC and FTXH
How have the GDOC and FTXH ETFs performed in 2026?
As of September 18, 2026, GDOC is up 4.02% year-to-date (YTD), while FTXH has returned 26.05%. That puts FTXH better performer ahead so far this year.
Which ETF is attracting more investor money: GDOC or FTXH?
Year-to-date, the GDOC ETF saw -$2M in flows, compared to +$1.11B for FTXH.
Which ETF is more volatile: GDOC or FTXH?
Over the past year, GDOC had a volatility of 15.27%, while FTXH experienced 17.58%.
Which ETF is bigger: GDOC or FTXH?
As of September 18, 2026, GDOC holds $19.46 M in assets under management (AUM), while FTXH manages $1.19 B.
What sectors do the GDOC and FTXH ETFs invest in?
GDOC leans toward sectors like Healthcare. Meanwhile, FTXH focuses on Healthcare.
What are the top holdings of the GDOC ETF and FTXH ETF?
GDOC top holdings include Eli Lilly & Co., Johnson & Johnson and Merck & Co., Inc.. FTXH holds in its top three: Merck & Co., Inc., Eli Lilly & Co. and AbbVie, Inc..
Which ETF is more diversified: GDOC or FTXH?
GDOC holds 38 securities with 71.18% of its assets in the top 15. FTXH has 49 securities and a top 15 weight of 66.98%.
Advertisement
Advertisement
